Kukje Pharma Co., Ltd. (KRX: 002720)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,955.00
-125.00 (-2.46%)
Dec 19, 2024, 3:30 PM KST
-27.13%
Market Cap 98.76B
Revenue (ttm) 150.12B
Net Income (ttm) 4.11B
Shares Out 20.36M
EPS (ttm) 202.05
PE Ratio 24.00
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 111,967
Open 5,000.00
Previous Close 5,080.00
Day's Range 4,935.00 - 5,020.00
52-Week Range 4,365.00 - 8,120.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Mar 17, 2025

About Kukje Pharma

Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, quinolones, tetracycline, aminoglycosides, macrolides, other antibiotics, ophthalmic, antifungal and antiviral agents, ophthalmic agents, adrenal corticosteroids, CNS and osteoporotic agents, antihistamines, NSAID... [Read more]

Sector Healthcare
Founded 1959
Employees 244
Stock Exchange Korea Stock Exchange
Ticker Symbol 002720
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.